Clinical Trial Update: Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a combination of temsirolimus, carboplatin, and paclitaxel in adults with advanced solid tumors, including ovarian and endometrial canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Epithelial Cancer
• Ovarian Germ Cell Tumor
• Ovarian Sarcoma
• Ovarian Stromal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ovarian Sarcoma, Ovarian Stromal Cancer | Phase 1 | Status: COMPLETED